Studies on claudin expression in various cancers provide heterogeneous data, though upregulation of CLDN1, −3 and −4 has been repeatedly reported for colon cancer, and up- and dysregulation of CLDN4 and −18.2 have been shown in gastric tumors [22,23,24,25]. Here, CLDN4 is linked to gastric neoplasm.